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http://www.biomedcentral.com/1471-2288/15/1RESEARCH ARTICLE Open AccessAssessing the validity of the Global Activity
Limitation Indicator in fourteen European
countries
Nicolas Berger1,2, Herman Van Oyen1*, Emmanuelle Cambois3, Tony Fouweather4, Carol Jagger4,
Wilma Nusselder5 and Jean-Marie Robine6,7Abstract
Background: The Global Activity Limitation Indicator (GALI), the measure underlying the European indicator
Healthy Life Years (HLY), is widely used to compare population health across countries. However, the comparability
of the item has been questioned. This study aims to further validate the GALI in the adult European population.
Methods: Data from the European Health Interview Survey (EHIS), covering 14 European countries and 152,787
individuals, were used to explore how the GALI was associated with other measures of disability and whether the
GALI was consistent or reflected different disability situations in different countries.
Results: When considering each country separately or all combined, we found that the GALI was significantly
associated with measures of activities of daily living, instrumental activity of daily living, and functional limitations
(P < 0.001 in all cases). Associations were largest for activity of daily living and lowest though still high for functional
limitations. For each measure, the magnitude of the association was similar across most countries. Overall, however,
the GALI differed significantly between countries in terms of how it reflected each of the three disability measures
(P < 0.001 in all cases). We suspect cross-country differences in the results may be due to variations in: the implementation
of the EHIS, the perception of functioning and limitations, and the understanding of the GALI question.
Conclusion: The study both confirms the relevance of this indicator to measure general activity limitations in the
European population and the need for caution when comparing the level of the GALI from one country to another.
Keywords: Global activity limitation indicator, Health expectancy, Disability-free life expectancy, Healthy life years,
Disability, Functioning, MeasurementBackground
Health expectancies are increasingly used as summary
measures of population health. Since 2005, the European
Union (EU) has monitored an indicator of life expect-
ancy without activity limitations, known as “Healthy Life
Years” (HLY). Increasing HLY is crucial for the EU in
order to reduce the social and economic burden associ-
ated with life expectancy lengthening. The European
Innovation Partnership on Active and Healthy Ageing is
targeting a two-year increase in HLY by 2020 [1,2].* Correspondence: hvanoyen@wiv-isp.be
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Dedication waiver (http://creativecommons.or
unless otherwise stated.The European Commission deployed efforts to harmon-
ise the data used in EU Member States to measure HLY,
in contrast to other health expectancies data which often
lack international harmonisation [3]. The Statistics of
Income and Living Conditions (SILC) survey, coordinated
by Eurostat, provides the data on activity limitations via
the Global Activity Limitation Indicator (GALI). The
GALI belongs to the family of disability indicators, target-
ing situations in which health disorders and conditions
have impacted people’s usual activities. It is a single-item
survey instrument which was developed with an explicit
definition of the underlying concepts, which facilitates its
translation and inclusion into different European surveys
[4]. Since the inclusion of the indicator in the SILC, there
have been efforts to improve its harmonisation, includingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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2008.
Despite harmonisation in data collection, cultural un-
derstanding and differences in reporting may threaten
(cross-national) validity of the GALI. In Belgium, the
GALI performed appropriately against other health indi-
cators [4]. In France, the GALI was also strongly associ-
ated with functional and activity limitations, but the
association with these other measures varied by educa-
tion level and employment status, independently of the
level of general health [5,6]. A first cross-national study
[7] including 11 countries from the Survey of Health,
Ageing and Retirement in Europe revealed consistent re-
lationships across countries between the GALI and other
measures of disability in the older population. Whether
these results hold for the wider adult European popula-
tion remains unknown.
Using data from the European Health Interview Survey
(EHIS), we assessed how the GALI is associated with other
measures of disability, and whether the GALI is consistent
or reflects disability differently among adults in 14 European
countries. Our study, which is part of the EU Joint Action
on Healthy Life Years [8], contributes to a better under-
standing of the European indicator HLY in providing a
first cross-validation of the GALI in adults aged 15 years
and older.
Methods
Data
The EHIS was conducted between 2007 and 2010 in indi-
viduals aged 15 years and older in 19 countries. Relevant
data from 14 countries was available at the time of the
analysis: Belgium, Bulgaria, Cyprus, Czech Republic,
France, Greece, Hungary, Latvia, Malta, Poland, Romania,
Slovakia, Slovenia, and Spain (Table 1). Microdata were
analysed at the premises of Eurostat. Procedures
for application for access to the microdata are given
by Eurostat (http://ec.europa.eu/eurostat/web/microdata/
overview).
The sample sizes range from 1,955 (Czech Republic)
to 35,100 (Poland) persons per country, representing the
adult population (including institutional population in
Belgium, Czech Republic, France and Malta). Response
rates varied between 56.0% (Czech Republic) and 95.5%
(Greece). Proxy interviewing was used in most countries
(varying from 0.7% (Greece) to 26.0% (Cyprus)) and par-
ticipation was mandatory for Cyprus, France, Spain and
Greece [9].
The EHIS questions were implemented either as one
specific survey or as elements of existing national sur-
veys, following Eurostat translation protocols from the
original English questionnaire. Sampling design and data
collection methods varied from country to country [9],
but (normalised) sampling weights were available for theanalyses. Examination of the question wording and re-
sponses categories revealed missing questions or compar-
ability problems in some countries [10]. Non-comparable
variables were considered as missing in these countries.
For each respective analysis countries with missing vari-
ables were excluded along with the respondents who had
missing values on the key variables.Measurements
Global Activity Limitation Indicator (GALI)
The Global Activity Limitation Indicator (GALI) is a
single-item survey instrument reported by the individual
him or herself to assess health-related activity limitations:
“For at least the past six months, to what extent have you
been limited because of a health problem in activities
people usually do?”. Possible responses are: severely lim-
ited, limited but not severely and not limited at all. The in-
dicator refers to general restrictions in activity without
specifying the type of activity concerned (work, household
chores, leisure, personal care etc.). Because of the low
numbers reporting themselves as severely limited, severe
and moderate limitations were merged into one category
(limited), as is commonly done when calculating the HLY
indicator [11].Limitations in activity of daily living (ADL)
Difficulties in activities of daily living correspond to the
most severe level of activity limitations [12]. The meas-
ure is based on the difficulty or need of assistance for
basic activities everyone is expected to perform inde-
pendently: washing, getting (un)dressed, feeding, getting
in and out of bed,
using the toilet. Severe difficulties with these activities
reflect situations of dependence requiring human assist-
ance. These situations create social exclusion in many
areas of life. ADL scores (‘any ADL’ and ‘sum of ADL’)
were created using 5 activities of daily living questions,
independently of the level of severity [13].Limitation in instrumental activity of daily living (IADL)
Difficulties in instrumental activities of daily living are
broader than ADL limitations and concern domestic ac-
tivities which allow an individual to live independently
[14]: difficulty or need of assistance for preparing meals,
using the telephone, shopping, managing medication,
doing light housework, doing occasional heavy house-
work, taking care of finances and everyday administra-
tive tasks. IADL scores (‘any IADL’ and ‘sum of IADL’)
were created using 7 instrumental activities of daily living
questions, independently of the level of severity [13]. A fil-
ter was applied to the IADL questions to account exclu-
sively health-related limitations.
Table 1 Characteristics of the European Health Interview Survey population, by countrya, 2007-2010
Belgium Bulgaria Cyprus Czech Republic France Greece Hungary Latvia Malta Poland Romania Slovakia Slovenia Spain
Data collection year 2008-9 2008 2008 2008 2008 2009 2009 2008 2008 2009 2008 2009 2007 2009-10
Sample size (N) 9,651 5,661 6,931 1,955 24,689 6,172 5,051 6,458 3,669 35,100 18,172 4,972 2,118 22,188
response rate (%) 60.0 73.8 81.6 56.0 - 95.5 80.6 72.0 72.0 72.0 89.0 66.0 - 74.0
Mean age (yrs) 47.1 46.6 43.3 44.4 46.3 47.3 47.3 45.3 46.8 44.6 44.4 43.3 46.0 46.5
% Male 48.1 47.9 49.2 48.6 47.8 48.8 46.6 45.3 46.4 47.6 48.3 48.1 49.1 49.0
GALI % limited 20.8 24.1 18.1 27.8 25.2 22.8 41.0 43.6 24.6 24.6 22.5 38.2 36.3 24.4
ADL % having difficulty with 1 or more activity 10.1 10.3 5.3 10.1 3.4 6.5 14.3 12.1 5.8 9.4 5.9 9.6 15.7 7.3
IADL % having difficulty with 1 or more activity - 23.1 13.0 14.2 - 18.2 18.5 23.2 9.7 18.4 12.3 13.7 18.3 14.3
Functioning % limited 26.2 28.2 20.3 21.6 27.6 28.6 32.7 33.8 27.2 21.4 28.6 27.3 30.3 26.9
GALI Global Activity Limitation Indicator, ADL activities of daily living, IADL instrumental activities of daily living.
aResults account for survey designs using sampling weights.
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Functional limitations refer to difficulties in performing
basic actions used in daily life [15]. Unlike ADL/IADL
indicators, the functional limitations indicator evaluates
the level of severity: severity of functional limitations -
as opposed to the number of domains with limitations -
impacts more directly the risk of meeting difficulties in
activities. A summary variable measuring functioning by
severity (no limitation; any moderate but no severe limi-
tation; any severe limitation) was constructed from 6
items assessing the extent of limitation in physical ac-
tions: walking a certain distance, going up or down
stairs, squatting and kneeling, carrying in the hands or
in the arms, using hands and fingers to manipulate small
objects, biting and chewing [16,17]. A dichotomous vari-
able (any limitation vs. none) was also constructed.
General approach
To investigate the validity of the GALI, we compared it
with three standard measures of disability. None of these
instruments is a gold standard for the GALI, but positive
associations with the GALI are expected. The GALI taps
limitations in the performance of social roles and activ-
ities (such as work, school, parenting, leisure) and has a
broader definition of activity than ADL and IADL mea-
sures [4,16]. Association of IADL and ADL measures
with the GALI should be strong and stronger for the
ADL measure, which captures more disabling limitations
than the IADL measure [7]. Most people reporting daily
activity limitations should report global activity limita-
tions; but, some individuals reporting global activity lim-
itations might be limited in other activities than basic
daily activities.
In the disablement process, functional limitations im-
mediately precede activity limitations [15]. Since individ-
uals with functional limitations have a higher risk of
being limited in activities, we expect some individuals
with functional limitations to report activity limitations.
However, not all individuals with functional limitations
have long-term limitations in their activities, so the asso-
ciation between the GALI and functional limitations
could be weaker than with daily activity limitations.
In addition to examining patterns in the associations
across all countries, this study further evaluates to what
extent the magnitude of these associations varies be-
tween countries.
Statistical methods
The relationships between the GALI and three measures
of disability was investigated 1) in the European popula-
tion as a whole, and 2) in every country separately,
which allowed us to test whether the relationships were
consistent in different countries. We performed add-
itional analyses, restricted to those aged 50 years andover, for comparison with those reported by Jagger et al.
using the Survey of Health, Ageing and Retirement in
Europe (SHARE) [7].
1) Pooled analyses: for every measure used to evaluate
the GALI (sum of ADL, sum of IADL and functional
limitations by severity; all treated as categorical
variables), a logistic regression model was fitted,
adjusting for the effects of gender, age (measured in
years) and interactions between the predictors, if
statistically significant (α = 0.05). The probability of
being classed as limited or not limited for the GALI
was estimated for each category or value of the
measure of interest. The relationship between the
GALI and each measure was assessed.
2) Country-specific analyses: treating each national
EHIS sample separately, logistic regression models
were fitted to estimate the odds ratios between the
GALI and each disability measure (dichotomised as
no limitation vs. at least one limitation), adjusting
for age and gender. We used dichotomised versions
of the disability measures to avoid sparseness and to
ease comparability with the SHARE study. Random-
effect meta-analysis models were then fitted using
country-specific odds ratios from the logistic
regression models (odds ratios >100 were excluded).
We assessed heterogeneity between countries in the
association between the GALI and the three other
measures with Cochran’s Q test and Higgins I2
statistic [7,18,19].
Results
The 14 countries were fairly similar in terms of age and
gender compositions, with a mean age of between 43.3 years
(Cyprus and Slovakia) and 47.3 years (Greece and Hungary)
and a proportion of men varying from 45.3% (Latvia) to
49.2% (Cyprus) (Table 1).
The percentage reporting global activity limitations var-
ied widely by country and was lowest in Cyprus (18.1%)
and highest in Latvia (43.6%). When compared to the
SILC 2009, these figures were higher in 7 countries (i.e.
more than 5% differences), as illustrate age-standardised
and gender comparisons (Additional file 1).
The distribution of limitations measured by the other
measures of disability also showed substantial variations
by country. The percentage with at least one ADL limi-
tation was lowest in France (3.4%) and highest in
Slovenia (15.7%); the percentage with at least one
IADL limitation was lowest in Malta (9.7%) and highest
in Latvia (23.2%); and the percentage with at least one
functional limitation was lowest in Cyprus (20.3%) and
highest in Latvia (33.8%). The magnitude of limitations
converged across the four measures in some countries:
Hungary, Latvia and Slovenia displayed high levels of
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among the lowest prevalence levels.
We then examined the global association between the
GALI and other disability measures. Of people reporting
ADL and IADL limitations, 89% and 82% respectively
were likely to report global activity limitations (Table 2).
The probability to report global activity limitations
among those who have neither ADL nor IADL limitations
was about 20%. A third of people with functional limi-
tations did not consider themselves as limited in their
activities. People who reported none of the functional
limitations listed in the questionnaire had a very low
probability of reporting global activity limitations.
The probability of reporting limitation based on the
GALI increased as the number of ADL and IADL limita-
tions increased (up to about 99% for respectively 5 and 7
ADL/IADL limitations) (Figure 1). The association was
less pronounced with functional limitations by severity
(no functional limitation: 14%; at least one severe func-
tional limitation: 76%).
Next, we determined whether the GALI measured dis-
ability similarly across countries, that is, whether indi-
viduals identified as having disability, defined using
ADL, IADL or functional limitations, had similar prob-
abilities of reporting GALI limitations between the differ-
ent EU countries. Results from the meta-analyses revealed
significant positive associations of the GALI with each
measure (Figure 2). In all countries, respondents with dis-
ability were more likely to report limitations based on the
GALI (P < 0.001 in all cases), indicating a consistency in
the associations. The overall odds ratios estimated from
the meta-analyses were largest for ADL (15.4), intermedi-
ate for IADL (11.4) and lowest though still high for func-
tional limitations (6.7). The more selective the disability
indicator, the stronger the association with the GALI: indi-
viduals with more severe types of disability are more
prone to report global activity limitations than people with
milder forms of disability.Table 2 Predicted probability of the GALI-defined activity
limitations by other measures of disability, European
Health Interview Survey, 2007-2010
GALI
Not limited Limited
ADL limitations No 0.78 0.22
1+ 0.11 0.89
IADL limitations No 0.82 0.18
1+ 0.18 0.82
Functional limitations No 0.86 0.14
1+ 0.34 0.66
GALI Global Activity Limitation Indicator, ADL activities of daily living, IADL
instrumental activities of daily living.
Figure 1 Probability distribution of the GALI against other
measures of disability, European Health Interview Survey,
2007-2010. (a) activities of daily living (ADL) limitations; (b)
instrumental activities of daily living (IADL) limitations; (c) physical
functional limitations. No comparable data were available for
Belgium and France in (b).Heterogeneity in the size of the odds ratios reached
statistical significance in all analyses (P < 0.001; I2 > 50%):
the relationship between the GALI and other measures
was more pronounced in some countries compared with
others. For instance, the odds of being limited by the
Figure 2 Cross-country comparison of association between
the GALI and other measures of disability, European Health
Interview Survey, 2007-2010. (a) activity of daily living (ADL)
limitations; (b) instrumental activities of daily living (IADL) limitations;
(c) physical functional limitations. Weights are from random effects
analysis. Slovakia (a) and Romania (b) were excluded because of
extreme values (odds ratio (OR) > 100) and no comparable data were
available for Belgium and France in (b). Source: European Health
Interview Survey.
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ADL compared with none varied from 6.7 (95% CI: 4.7,
9.4) for Slovenia to 53.2 (95% CI: 35.6, 79.6) for
Romania. Variability in the point estimates of the odds
ratios was intermediate for IADL (odds ratios varying
from 7.4 to 26.3) and lowest for functioning (odds ratiosvarying from 4.2 to 11.7; 85% of the odds ratios com-
prised between 5.2 and 8.7).
However, most countries showed consistent patterns
of associations with the GALI for ADL and IADL analyses,
but not for functioning: countries with a strong association
between the GALI and ADL also tended to exhibit a
strong association between the GALI and IADL. For in-
stance, Bulgaria had odds ratios of 14.8 and 14.5 in ADL
and IADL analyses respectively.
Overall, the size of the associations differed between
countries, but the pattern within countries was the same:
stronger associations between ADL and IADL and the
GALI, weaker association with functional limitations.
Discussion
When considering each country separately or all com-
bined, we found that the GALI consistently appeared
to be a good indicator of disability in the adult popula-
tion, corroborating previous studies [4,7]. Our study
confirmed a stronger association between the GALI
and ADL, intermediate with IADL and somewhat lower
with functioning.
We further observed that the strength of the associa-
tions that relates the GALI to disability measures varied
across countries. Further analyses (not reproduced here)
using different subsets of countries (EU-15 countries; ex-
cluding outliers; or excluding countries with large sam-
ple sizes (Belgium, France, Poland, Romania, Spain))
reached similar conclusion. This result partly challenges
a former study of the older European population, using
the SHARE [7]. To understand differences in the results,
we mimicked the SHARE study using the EHIS partici-
pants aged 50 years and older (see Additional file 2).
Comparison with the SHARE was possible for ADL and
IADL analyses although the questions slightly differed
between the two surveys. Apart from some extreme odds
ratios, results were very comparable. Countries included
in both studies had comparable estimates (i.e. Belgium,
Greece and Spain), with the exception of France which
had an extreme value in our study due to lower ADL limi-
tations compared to other countries. Yet, our study had
more power and reached statistical significance for both
ADL and IADL heterogeneity tests even after the exclu-
sion of outliers, whereas the SHARE study found signifi-
cant heterogeneity for IADL only.
It appears that the main difference with the SHARE
study was that, in our study, ADL and IADL measures
were extremely strong predictors of the GALI in some
countries. Respondents of those countries tended to as-
sociate ADL and IADL measures to the GALI more
often. For example, in Romania, 99.8% of the respondent
who reported no IADL limitations, reported no limitation
on the GALI. We did not find these high associations in
other countries.
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these differences. The SHARE survey methodology is
centrally managed with no room for variability in the
survey mode and method. As opposed to SHARE, the
EHIS is not implemented homogeneously across coun-
tries, resulting in various administration modes, popula-
tion and sampling frames (e.g. inclusion or exclusion of
the institutionalised population), sampling designs, item
non-responses rates, uses of proxies and even question
orders [9]. These survey characteristics impact survey
responses [20,21] and are likely to hamper comparability
if they change from country to country. For example,
item non-response rates varied greatly across countries
and may cause different selection biases. For IADL, the
proportion of individuals analysed was highest in Cyprus
(almost 100%) and lowest in Poland (87%).
Another explanation may come from the self-reported
nature of the data. The GALI and the other measures of
disability are subject to social and cultural variations in
reporting, even in perfectly harmonised surveys. Vari-
ation in the GALI prevalence and in its association with
other measures may therefore be influenced by reticence
about reporting global activity limitations or other types
of disability. This may explain why the SHARE study
found no significant cross-country variability in the asso-
ciation between the GALI and the objective measures of
disability (i.e. maximum grip strength and walking speed).
As to the GALI itself, it particularly triggers reporting var-
iations by referring to usual activities in the question:
“have you been limited […] in activities people usually do”.
Depending on age, culture, social background and coun-
try, individuals may interpret limitations in usual activities
differently, independently of their disability situation. In
order to account for heterogeneity in reporting styles, re-
cent statistical techniques using anchoring vignettes were
developed [22]. For example, such vignettes enabled the
estimation of cross-country differentials in work disability
reporting [23]. Having such tools for the GALI question
would certainly contribute to better understanding of the
threshold used by respondents to report or not to report
activity limitations.
Our study is the first comprehensive evaluation of the
GALI in the adult population of 14 European countries.
Its strengths are the number of countries covered in the
EHIS survey and the data quality in terms of the range
of measures of disability, the sample sizes and popula-
tion coverage (i.e. the whole adult population). A limita-
tion is the differential survey methods across the EHIS
participating countries.
As we validated the GALI using measures which are
also self-reported, we could not, in contrast to the SHARE
study [7], demonstrate that the GALI reflects objectively
measured activity limitations. What we showed, however,
is that the GALI performs well for reporting perceivedactivity limitations. We confirmed that the GALI is a use-
ful global instrument for measuring activity limitations in
the fashion self-rated health assesses general health status.
The GALI - as the measure underlying the European
indicator HLY - should be validated in the adult European
population. The fact that, in most countries, we observed
consistent and gradual associations with the GALI for
ADL, IADL and functioning is encouraging and suggests
that the GALI question is understood similarly in different
countries. Yet, a few countries stood out by extreme re-
sults. We suspect that the lack of harmonisation of the
EHIS is responsible for these inconsistencies. That is to
say, we may be facing an issue of survey data comparabil-
ity rather than one of cross-national validity of the GALI
itself [24].
Whether this explanation holds or not, our results have
implications for the indicator HLY when based on the
EHIS. HLY based on the SILC - which is the data source
for the indicator - may suffer from similar harmonisation
problems at the level of the implementation of the survey
[25]. Similar outlying countries are therefore likely to exist
in the SILC data, which may in turn influence the HLY fig-
ures and hamper their comparability. We believe that im-
proving further the harmonisation of the data collection
of the EHIS and the SILC across the European countries
is necessary to enhance the quality of the HLY figures
across Europe. Further understanding of the methodo-
logical, cultural and health factors influencing the GALI is
needed in order to fully validate and compare HLY figures
across countries.
Conclusion
The study both confirms the relevance of the GALI to
measure general activity limitation in the European popu-
lation and highlights the need for caution when compar-
ing the levels of the GALI from one country to another;
analysis of patterns and trends should be preferred when
looking at European disability and HLY.Additional files
Additional file 1: Age-standardised comparison of the GALI
distribution (% limited) between the EHIS and the SILC 2009.
Table comparing the GALI distribution by gender between the EHIS
(European Health Interview Survey) and the SILC (Statistics on Income
and Living Conditions) in 14 European countries. Results are
age-standardised.
Additional file 2: Cross-country comparison of association between
the GALI and other measures of disability in adults aged 50 years
and older. Figure describing the results of random-effect meta-analysis
models to estimate the odds ratios between the GALI and (a) activity of
daily living (ADL) limitations; (b) instrumental activities of daily living (IADL)
limitations in adults aged 50 years and older. Slovakia (a) and Romania (b)
were excluded because of extreme values (Odds Ratio (OR) > 100) and no
comparable data was available for Belgium and France in (b). Source:
European Health Interview Survey.
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